Home › Blog › NMN and Menopause UK 2026
📅 Updated July 2026 · ⏱ 12 min read · 🇬🇧 UK-focused
NMN and menopause is one of the most searched supplement topics in the UK — and one of the most poorly covered. Most content either overclaims or ignores the research entirely. This guide takes a different approach: covering what has actually been published, in which populations, and what the evidence does and does not address.
This is general educational information. We are a UK NMN manufacturer with a commercial interest — we flag that clearly at the top of every NMN guide we produce. The published research papers are linked in our references below so you can read the actual findings for yourself. We are not stating what those papers demonstrate as a benefit of our products.
NMN is a food supplement. It is not a medicine. It is not hormone therapy. It is not a substitute for HRT. For menopause symptom management, always speak to your GP or gynaecologist first.
In This Guide
1. Why NAD+ and Menopause Are Biologically Connected
To understand why NMN is discussed in a menopause context you need to understand two things happening simultaneously during the menopausal transition — and how they interact biologically.
The Double Decline
Oestrogen Decline
Regulates insulin sensitivity, glucose metabolism, fat distribution, mitochondrial function, sleep architecture and thermoregulation. Begins declining in perimenopause — often years before periods stop.
NAD+ Decline
Declines significantly with age — a well-documented biological fact. NAD+ is a coenzyme involved in cellular energy production and mitochondrial function. This decline occurs alongside oestrogen decline during the menopausal transition.
Published research (Wang et al., 2023, International Journal of Molecular Sciences) has examined the relationship between oestrogen receptor signalling, NAD+ biosynthesis and mitochondrial function in female reproductive tissues. This published biology is the reason there is specific scientific interest in NMN during the menopausal transition — distinct from general longevity interest.
⚠️ The above is a description of published biology — not a claim that NMN supplementation will produce any specific outcome during menopause. General educational information only. Food supplement — not a medicine.
2. Which Human Trials Have Enrolled Women
Two significant published human NMN trials have specifically enrolled postmenopausal women. We describe the trial designs and populations below — we are not stating what those trials demonstrated as a benefit of our products. Please read the papers yourself using the PubMed links in our references.
Yoshino et al. (2021) — Science journal · PubMed 33888596
This is the most cited human NMN trial in existence. It was conducted specifically in postmenopausal women. Please read the published paper for the full findings — we are not stating what it demonstrated as a benefit of our products. PubMed 33888596.
Yonei et al. (2022) — Glycative Stress Research · Doshisha University, Japan
A second published trial in postmenopausal women. Please read the published paper for the full findings — we are not stating what it demonstrated as a benefit of our products.
⚠️ Important context: As of 2026, very few published studies have enrolled perimenopausal women specifically. Most relevant data comes from postmenopausal women and older adults. Published trial populations may not represent all stages of the menopausal transition. General information only — not health claims. Food supplement — not a medicine.
3. Specific Menopause Symptoms — What Research Areas Cover
The following describes published research areas only — it does not state that NMN supplementation will produce any specific outcome. Mechanistic plausibility ≠ proven benefit. General information only. Food supplement — not a medicine.
⚡ Energy and Fatigue
Both NAD+ and oestrogen are involved in mitochondrial energy production. Published biology describes their simultaneous decline during menopause. Whether NMN supplementation specifically addresses menopause-related fatigue has not been tested in a dedicated controlled trial. Educational context only — not a product claim.
😴 Sleep Disruption
Published biology describes NAD+ as a regulator of circadian clock proteins via SIRT1 activation. A published trial in older adults (65–75 years) examined NMN at 250mg daily for 12 weeks and measured sleep quality scores — see PubMed reference below for findings. Whether this applies to menopause-specific sleep disruption has not been directly tested in that population. Educational context only — not a product claim.
🧠 Brain Fog and Cognitive Symptoms
Neuronal function is energy-intensive and NAD+-dependent. Oestrogen also plays a role in brain energy metabolism. Whether NMN specifically addresses menopausal cognitive symptoms has not been tested in a controlled trial. Educational context only — not a product claim.
💪 Muscle Health and Metabolic Function
The Yoshino 2021 trial specifically enrolled postmenopausal women and examined metabolic function markers. Please read the published paper for the full findings — PubMed 33888596. We are not stating what it demonstrated as a benefit of our products. This is the area with the strongest published human trial basis in postmenopausal women. Educational context only — not a product claim.
4. 🌡️ Hot Flushes — The Honest Position
Mechanistic plausibility
⚠️ Weak — hot flushes are driven by hypothalamic thermoregulation changes secondary to oestrogen fluctuation — not directly addressed by NAD+ supplementation
Published human trial evidence
❌ None — no published human clinical trial has examined NMN specifically for hot flush reduction
Any brand claiming NMN reduces hot flushes is making an unsupported claim. We do not make this claim. Individual anecdotal reports exist but cannot be distinguished from natural variability or placebo effect without controlled trial data. Food supplement — not a medicine.
5. Magnesium Glycinate — The Complementary Partner
Magnesium glycinate addresses several common menopause experiences through completely different pathways to NMN — and the two complement each other logically rather than duplicating. Magnesium has 9 authorised EU/UK health claims under retained Regulation 1924/2006 — these are the legally established claims for magnesium.
| Authorised Claim for Magnesium | Relevant to Menopause Because |
|---|---|
| Reduction of tiredness and fatigue | Fatigue is one of the most commonly reported menopause experiences |
| Normal psychological function | Mood changes are common during the menopausal transition |
| Normal functioning of the nervous system | Nervous system regulation supports sleep and stress response |
| Normal muscle function | Muscle tension and cramps are common during perimenopause |
| Maintenance of normal bones | Oestrogen decline accelerates bone density loss post-menopause |
| Normal energy-yielding metabolism | Energy metabolism is affected by both oestrogen and NAD+ decline |
These are the only claims made for magnesium glycinate — authorised under retained EU Regulation 1924/2006. Food supplement — not a medicine.
NMN + Magnesium Glycinate — Complementary Pathways
NMN → NAD+ Pathway
Cellular energy (ATP via mitochondria) · circadian regulation via SIRT1 · metabolic function
Magnesium Glycinate Pathway
GABA modulation · sleep initiation · HPA axis · muscle relaxation · ATP cofactor · bone mineral support
We offer NMN and Magnesium Glycinate separately and as a combined 800mg capsule (400mg NMN + 400mg Magnesium Glycinate) — in-house encapsulated, no fillers, vegan HPMC. Same Eurofins-sourced NMN as our standalone capsules. Food supplement — not a medicine.
6. ⚠️ NMN Is Not Hormone Therapy — This Needs to Be Stated Clearly
NMN does not replace oestrogen. It does not increase oestrogen production. It is not a substitute for HRT or other menopause treatments.
NMN works through NAD+ and sirtuin pathways. These pathways interact with but do not replace hormonal signalling. Women with significant menopause symptoms should discuss HRT options with their GP or gynaecologist. HRT has a substantially stronger evidence base for managing menopause symptoms than any supplement.
Food supplement — not a medicine. Always consult your GP.
7. Practical Considerations
General information based on published trial protocols. Not personalised medical advice. Consult your GP before starting. Food supplement — not a medicine.
| Consideration | Basis |
|---|---|
| 250–500mg NMN daily as a starting point | Consistent with doses used in published postmenopausal women trials |
| Morning with breakfast | Consistent with timing used in published positive NMN trials |
| Magnesium glycinate in the evening | Complements NMN's circadian mechanism — different pathway |
| 8–12 weeks minimum | Published postmenopausal women trials ran 8–10 weeks |
| Consult your GP first | Especially if on HRT, statins, antidepressants or other prescription medications |
| Do not use as a substitute for HRT | If symptoms are impacting quality of life — discuss HRT with your GP first |
Our Products
Food supplements — not medicines. 99.99% pure β-NMN · Eurofins tested · in-house UK encapsulation · 5 Star FSA · 161,000+ verified sales.
FAQ — NMN and Menopause 2026
Has NMN been studied in menopausal women?
Yes. The Yoshino et al. 2021 trial (Science journal) was conducted specifically in postmenopausal women. The Yonei et al. 2022 Japanese trial also enrolled postmenopausal women. We link both papers in our references — please read them for the actual findings. General information only — not health claims. Food supplement — not a medicine.
Does NMN reduce hot flushes?
No published human clinical trial evidence supports this. Hot flushes are driven by hypothalamic thermoregulation changes secondary to oestrogen fluctuation — not directly addressed by NAD+ supplementation. Food supplement — not a medicine.
Can I take NMN instead of HRT?
No. HRT has a substantially stronger evidence base for managing menopause symptoms than any supplement. NMN and HRT operate through completely different mechanisms. If significant symptoms are impacting your quality of life — discuss HRT with your GP first. Food supplement — not a medicine.
What dose was used in the postmenopausal women trials?
Yoshino 2021 used 250mg NMN daily for 10 weeks. Yonei 2022 used 300mg daily for 8 weeks. Please read the actual papers using the PubMed links below — we are not stating what they demonstrated as a benefit of our products. Food supplement — not a medicine.
Can I take NMN and magnesium glycinate together?
Yes — they work through different pathways. NMN works through NAD+/sirtuin pathways. Magnesium glycinate works through GABA modulation, ATP cofactor activity and HPA axis regulation. We offer a combined 800mg capsule. Always consult your GP before starting. Food supplement — not a medicine.
Is NMN safe during menopause?
Published human trials including those in postmenopausal women report no serious adverse events at the doses studied. Always consult your GP before starting NMN if you are on HRT, statins, antidepressants or other prescription medications. Food supplement — not a medicine.
Where can I buy NMN in the UK for menopause support?
Charge Products (Big Idea Services Ltd, Co. No. 11645389) — UK in-house NMN encapsulator since 2016. 5 Star FSA. 161,000+ verified sales. Available in 500mg capsules, 700mg capsules, NMN powder and combined NMN + Magnesium Glycinate 800mg capsules. Same-day UK dispatch before 3:30pm. Food supplement — not a medicine.
📚 Published Literature Referenced
Links provided so you can read the actual research. We are not stating that these papers demonstrate benefit from our products — provided for educational reference only.
Yoshino et al. (2021) — NMN trial in postmenopausal women with prediabetes · Science
PubMed 33888596 →Yonei et al. (2022) — NMN trial in postmenopausal women · Glycative Stress Research
Doshisha University, Japan · 300mg/day · 8 weeks
Wang et al. (2023) — Oestrogen receptor and NAD+ biosynthesis · International Journal of Molecular Sciences
PubMed 37175654 →Ramsey et al. (2009) — SIRT1 and circadian clock regulation via NAD+ · Science
PubMed 19833968 →Bannai et al. (2012) — Glycine and sleep quality · Sleep and Biological Rhythms
PubMed 23341586 →Holmes HE et al. (2026) — NAD+ precursors and menopausal transition · Frontiers in Aging
doi.org/10.3389/fragi.2026.1773667 →Commonly searched as: NMN menopause UK · NMN perimenopause UK · NMN postmenopause · NMN menopause symptoms · NMN hot flushes UK · NMN menopause fatigue · NMN brain fog menopause · NMN sleep menopause · NAD+ menopause UK · NMN women over 50 UK · NMN oestrogen · best supplement menopause UK · NMN magnesium glycinate menopause · magnesium glycinate menopause UK · magnesium menopause UK · NMN and HRT · NMN menopause 2026 · buy NMN UK menopause · NMN postmenopausal women trial · Yoshino NMN trial women · NAD+ perimenopause · Charge Products NMN menopause
